In April 2018, researchers from the University of Texas Medical Branch, Texas Health Science Center, and Baylor College of Medicine found that a type of cancer known as NCI-9, which causes tumors to grow slowly, had shrunk significantly in recent years.
That’s not good news for patients like the University’s J. Lee.
Lee, a cancer survivor, was told in a recent interview that her cancer was on the way to becoming a full-blown tumor, a rare but devastating prognosis that could lead to her death.
She is one of many people whose tumors are getting caught up in the slow-growing NCI.
“I’m so worried, I feel like I’m on the verge of losing my life,” Lee said.
But she has a plan.
She wants to fight back.
A small team of researchers led by David C. Gant and his colleagues has developed a drug called TAC-19, which targets a different type of tumor.
This drug is now being tested in clinical trials, and the hope is that it could be an effective cancer treatment.
The team also developed a novel drug called CIM-4 that targets a much more aggressive type of growth, called a colorectal adenocarcinoma.
This tumor has grown rapidly over the last decade, but there’s no way to know if it can be slowed down, or even stopped.
The two drugs have been tested in human trials and in mice.
“Our hope is to have a clinical trial in humans within six months of the FDA approval,” Gant said.
“But I don’t know how long that will take.”
The drug would be administered by injection and could be administered as a shot or by oral administration.
Unlike the drug approved by the FDA, CIM, which is currently undergoing testing in the U.S., is not a direct inhibitor of cancer cells.
Rather, it blocks the protein responsible for cell growth, known as NF-κB.
The goal of the drug is to prevent the cancer cells from growing and becoming a cancer, and to help the cancer shrink.
“We’re looking at the growth of tumors as the tumor, not as the cancer,” said Gant.
“That’s why we’re not treating the cancer as a cancer.”
The researchers believe that the drug could shrink a tumor by a factor of 10 or more over a 10-year period.
That might sound like a lot, but in fact, that’s far less than the amount of time it takes for cancer to mature.
“The goal is to shrink a cancer by a factorial factor of about 10 or 10, which might seem like a large number, but it’s actually a small number compared to the time it will take for the tumor to mature,” Gan said.
The drug is currently in the early stages of testing and is likely to be approved in the next year or so.
It’s a big step forward, but the researchers acknowledge that the drugs will not save all patients.
There are still millions of people with cancer that are not treated.
The drugs, for instance, have only been found in about a dozen people with metastatic disease, meaning they have not shown any benefit to patients who have died.
If the drug does work, Gant is optimistic that it can potentially help the vast majority of people who are treated.
“It’s a very, very, rare cancer, so if we can figure out a way to make it less rare, we can definitely save a lot of lives,” he said.
In fact, he said, he thinks that a vaccine could be a good idea.
In the meantime, it’s unclear whether the drugs are effective.
The research is just the latest in a long line of promising results from researchers working with cancer.
The work was published in the journal Science in September.
For more on cancer, watch: The discovery of CIM and its potential uses in the fight against cancer will likely have a profound effect on the world.
As with many cancers, cancer can grow slowly and slowly, and that’s not a good thing.
But this is not the only kind of growth that is growing in the world, and it’s getting worse.
In 2015, scientists reported finding that breast cancer is spreading faster than it was in the past.
This trend has been blamed on the increased use of breast implants, which increase the likelihood of cancer spreading.
In 2016, a study led by researchers at Johns Hopkins University found that some cancers are growing more rapidly than previously thought.
The researchers analyzed data from more than 1,000 people with cancers diagnosed in the United States between 2008 and 2015.
Of those, some 10 percent of the cancers were growing more quickly than expected.
Researchers also reported finding tumors growing at a rate of five times faster than they should have.
It turns out that breast tumors are growing at faster rates than previously believed.
So what’s going on?
The new study, for the first time, also found that certain cancers are being more aggressive